Enabling streamlined communication and access to the highly promising Middle East/GCC regions for biopharmaceutical and medical technology Sponsors.
Identifying qualified sites and highly motivated Investigators to support clinical studies and enable access to promising new treatments for Patients in a wide range of therapeutic areas.
PAPHOS, Cyprus, June 5, 2024 /PRNewswire/ — As the timeframe to develop a new therapy or technology is increasing along with competitive and high-risk nature of the industry, exploring emerging regions that offer better Patient access while maintaining regulations and standards for clinical research has become a necessity. Entering new regions is a daunting task, however. It involves numerous challenges and although the potential for success and development progress is attractive, often, study Sponsors choose to steer away from risk and “unknown” regions/situations.
“Leveraging our geographical location and extensive network of partners to promote clinical research in the MENA/GCC regions has been a key driver of our vision. Phoenix Clinical Research is a reliable and highly experienced service provider working closely with study Sponsors …
Leave a Reply